MONOD BIO, INC.
Bioluminescent biosensor for endotoxin detection without horseshoe crab components
- Sector
- Medtech
- Headquarters
- SEATTLE, WA
- Founded
- 2020
- Latest Form D
- $24.2M, Jun 2022
- Total capital
- $30.5M
- Federal grants
- $290K
- 1 award · 2023
- Rank in peer group#74 of 79
- Private capital raised
- $30.2M
- 2 Form D · last Jun 2022
- 52 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 11 pending
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase I · Novel Biosensor for Detection of Endotoxin$290K
- Private capital raisedForm D · SEC · 2nd filing$24.2M
- Private capital raisedForm D · SEC · 1st filing$6M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 79 peers
Line = medianMedtech · Instrument
- Federal grantsBelow median
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Alfredo Quijano RubioExecutive OfficerNamed in SEC Form D filings
- Berta Melina CimlerDirectorNamed in SEC Form D filings
- Daniel Adriano Silva ManzanoExecutive Officer, DirectorNamed in SEC Form D filings
- Dave Melina JohnsonDirectorNamed in SEC Form D filings
- David Melina ShoultzExecutive Officer, DirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 11- PendingEngineered Scaffold ProteinsUSPTOApplication PCTUS2025060767
- PendingINTERLEUKIN-18 MimeticsUSPTOApplication PCTUS2025060465
- PendingEngineered Luciferases and Luciferin SubstratesUSPTOApplication 19478669
Show all 11 patent records
- Engineered Scaffold ProteinsApplication PCTUS2025060767Pending
- INTERLEUKIN-18 MimeticsApplication PCTUS2025060465Pending
- Engineered Luciferases and Luciferin SubstratesApplication 19478669Pending
- Engineered Split LuciferasesApplication PCTUS2025052285Pending
- Engineered Scaffold ProteinsApplication 63736342Pending
- INTERLEUKIN-18 MimeticsApplication 63735803Pending
- Engineered Split LuciferasesApplication 63711582Pending
- Engineered Luciferases And Luciferin SubstratesApplication PCTUS2024026098Pending
- Engineered Luciferases And Luciferin SubstratesApplication 63625901Pending
- Bioluminescent Luciferin SubstratesApplication 63505939Pending
- Engineered LuciferasesApplication 63498236Pending
Related companies, and why
- ASSIST EQUIPMENT DEVELOPMENT, INC.Similar federal contract value in Medtech · null in contracts
- Lyra Therapeutics, Inc.Similar federal contract value in Medtech · null in contracts
- INOVASC, LLCSimilar federal contract value in Medtech · null in contracts
- Cylerus, Inc.Similar federal contract value in Medtech · null in contracts
- COOLER HEADS CARE INCSimilar federal contract value in Medtech · null in contracts
- Adient Medical Inc.Similar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .